ATC codes:
N05CD08
EMLc
Indication
Palliative care
ICD11 code:
QC7A
INN
Midazolam
Medicine type
Chemical agent
List type
Core
(EML)
(EMLc)
(EMLc)
Formulations
Oral > Liquid:
2 mg per mL
(EMLc)
Parenteral > General injections > unspecified: 1 mg per mL in 5 mL vial ; 5 mg per mL in 1 mL vial ; 5 mg per mL in 3 mL vial
Local > Buccal > Solution: ; 5 mg per mL in 0.5 mL pre-filled syringe (for oromucosal administration) ; 5 mg per mL in 1 mL pre-filled syringe (for oromucosal administration) ; 5 mg per mL in 1.5 mL pre-filled syringe (for oromucosal administration) ; 5 mg per mL in 2 mL pre-filled syringe (for oromucosal administration) ; 10 mg per mL in 0.25 mL pre-filled syringe (for oromucosal administration) ; 10 mg per mL in 0.5 mL pre-filled syringe (for oromucosal administration) ; 10 mg per mL in 0.75 mL pre-filled syringe (for oromucosal administration) ; 10 mg per mL in 1 mL pre-filled syringe (for oromucosal administration)
Oral > Solid > dosage form: 7.5 mg (EML) ; 15 mg (EML)
Parenteral > General injections > unspecified: 1 mg per mL in 5 mL vial ; 5 mg per mL in 1 mL vial ; 5 mg per mL in 3 mL vial
Local > Buccal > Solution: ; 5 mg per mL in 0.5 mL pre-filled syringe (for oromucosal administration) ; 5 mg per mL in 1 mL pre-filled syringe (for oromucosal administration) ; 5 mg per mL in 1.5 mL pre-filled syringe (for oromucosal administration) ; 5 mg per mL in 2 mL pre-filled syringe (for oromucosal administration) ; 10 mg per mL in 0.25 mL pre-filled syringe (for oromucosal administration) ; 10 mg per mL in 0.5 mL pre-filled syringe (for oromucosal administration) ; 10 mg per mL in 0.75 mL pre-filled syringe (for oromucosal administration) ; 10 mg per mL in 1 mL pre-filled syringe (for oromucosal administration)
Oral > Solid > dosage form: 7.5 mg (EML) ; 15 mg (EML)
EML status history
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Read more
about patents.
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended:
- the addition of midazolam solution for oral administration 5 mg/mL and 10 mg/mL to the EML and EMLc;
- the deletion of midazolam solid oral dosage forms from the EMLc;
- to modify the formulations descriptions of midazolam injection to better describe the available dosage forms.